The U.S. Food and Drug Administration approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.

According to a new study, the next 25 years will show a two-fold increase in the number of Americans with diabetes.

New studies show that targeting B cells slows beta-cell destruction and delays diabetes.